Nymox Announces Appointment of Andre Monette
February 05 2014 - 2:00PM
Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to
announce the appointment of Andre Monette as Chief Financial
Officer of the Company. Mr. Monette, who is a Chartered
Professional Accountant and Chartered Financial Analyst, brings to
the company extensive experience and expertise in the financial and
securities sectors as an executive in the securities industry and
as a CFO of a public company. Mr. Monette served for seventeen
years as Vice President of Finance and Administration for the North
American subsidiary of Lombard Odier Group, a private Swiss bank
based in Geneva. Prior to joining Nymox he provided corporate
consulting services in financial reporting.
Dr. Paul Averback, CEO, said, "We are very pleased to have Andre
joining Nymox management. His decades of international experience
in financial matters involving Europe and the U.S. will be
extremely valuable to the Company."
Dr. Averback said, "The Company thanks our departing CFO Roy
Wolvin for his service to the Company and wishes him the best in
his new endeavours."
More information about Nymox is available at www.nymox.com,
email: info@nymox.com, or 800-936-9669.
This press release contains certain "forward-looking statements"
as defined in the United States Private Securities Litigation
Reform Act of 1995 that involve a number of risks and
uncertainties. There can be no assurance that such statements will
prove to be accurate and the actual results and future events could
differ materially from management's current expectations. Such
factors are detailed from time to time in Nymox's filings with the
United States Securities and Exchange Commission and other
regulatory authorities.
CONTACT: Brian Doyle
Nymox Pharmaceutical Corporation
1-800-93NYMOX
www.nymox.com
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Apr 2023 to Apr 2024